Tamoxifen also may increase the risk of endometrial cancer in some women. Dealing with menopausal symptoms related to hormone therapy can be hard. Breastcancer.org is a registered 501(c)(3) nonprofit organization dedicated to providing information and community to those touched by this disease. The benefits of tamoxifen outweigh its risks in women already diagnosed with breast cancer.Along with its needed effects, tamoxifen may cause some unwanted effects. For some women with breast cancer, taking adjuvant tamoxifen (Nolvadex®) for 10 years after primary treatment leads to a greater reduction in breast cancer recurrences and deaths than taking the drug for only 5 years, according to the results of a large international clinical trial.. Other side effects include: infection, sepsis, alopecia, constipation, cough, diarrhea, edema, increased serum aspartate aminotransferase, infrequent uterine bleeding, menstrual disease, ostealgia, vomiting, and weight gain. I want to know about physical changes to the body.
At that time, the median follow-up was 10 years, and 25 percent of the … After surgery and other treatments (chemotherapy, radiation therapy), women diagnosed with early-stage, hormone-receptor-positive breast cancer usually take 5 years of a hormonal therapy medicine to lower recurrence risk (the cancer coming back). Thanks so much.
Healthline Media does not provide medical advice, diagnosis, or treatment. It's just a pill and not everyone that takes this med has side effects.I have a friend that was on some AI for 5 years and had absolutely no side effects, NONE.Well, I am not quite that lucky but for now the side effects that I do have are manageable.I've upped my intake of Vit D and calcium in the hopes of avoiding any significant bone density loss.The best thing about taking it, aside … I am 54 years old and looking for next steps after medication. Combined with the results of the ATLAS trial, these results are extremely promising and likely to change the hormonal therapy standard of care for women diagnosed with early-stage, estrogen-receptor-positive breast cancer.
The aromatase inhibitors have become the recommended adjuvant hormonal therapy for POSTmenopausal women diagnosed with hormone-receptor-positive, early-stage breast cancer. The typical recommended dosage is 20–40 mg per day taken in one or divided doses for 5 years… But since the cancer was caught early, she didn’t push the issue.“My husband and girls are very supportive because they saw how difficult the treatment was for me and want their wife and mom back. Our website services, content, and products are for informational purposes only. But, in the case of extended tamoxifen treatment, he argued, the "risks are far smaller than the benefits. Overall, 10 years of tamoxifen reduced breast cancer recurrence and death rates by an extra 25%, compared to 5 years of tamoxifen. Are there any books you recommend.
When they ask if I’m done with treatment, I say yes, and leave it at that,” she said.Nancy Hand of California has been taking tamoxifen for 14 months.“The only side effect I’ve noticed is hot flashes. See below for a comprehensive list of adverse effects.
Aromatase inhibitors are preferred over tamoxifen for postmenopausal women because a number of studies have shown that postmenopausal women treated with an aromatase inhibitor have a slightly lower recurrence risk than women treated with tamoxifen.
In this study, the researchers found that 10 years tamoxifen increased the risk of endometrial cancer compared to 5 years of tamoxifen.
Together, you can decide on a treatment plan that's best for YOU. All rights reserved.
Our website services, content, and products are for informational purposes only. You may report them to the The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. More than 22 percent said tamoxifen was a “mystery” to them.About 29 percent said doctors use too many medicines. After three years of follow-up, Arimidex treatment alone demonstrated superiority to tamoxifen or the combination. Of the adjuvant hormonal therapy choices, tamoxifen has been approved the longest and is approved to treat both premenopausal and postmenopausal women. Healthline Media does not provide medical advice, diagnosis, or treatment. The researchers then looked to see if recurrence risk was lower and survival was better in either group of women. Tamoxifen is used to treat breast cancer, womb cancer and sometimes other cancers and conditions.
But a woman at low risk of recurrence at any point "may very well rationally decide she doesn't want to take tamoxifen beyond 5 years," he added.The findings may have implications for postmenopausal women as well, said Claudine Isaacs, M.D., C.M., co-director of the breast cancer program at Georgetown Lombardi Comprehensive Cancer Center.Postmenopausal women are often prescribed 5 years of adjuvant therapy with an aromatase inhibitor.
Does anyone have any information on what to expect after 5 years of tamoxifen - I just finished 5 years of the medication this month. Learn more about Another Study Shows 10 Years of Tamoxifen Better Than 5 for Early-Stage, Estrogen-Receptor-Positive Disease